Summary of the technology
Fluidic device that allows high sample volume injection in HPLC systems and provides an automated purification step, reducing sensitivity problems and facilitating the analysis of extracted compounds from complex matrix.
Description of the technology
i) Therapeutic drug monitoring and forensic medicine;
ii) Environmental analysis e.g. pollutants in air, water, soil;
iii) Food quality evaluation
A LC-MS/MS method based on this fluidic device has been validated in the laboratory and is currently used for therapeutic drug monitoring (Imatinib and Norimatinib) of cancer patients. Miniaturization and automation are required for commercial use. Patent opportunities are currently under evaluation.
Current development status
Desired business relationship
Adaptation of technology to other markets
Other : Miniaturization
National Cancer Institute CRO Aviano
Additional information (attached documents)